Dysbiosis in the gut microbiota affects several systemic diseases, possibly by driving the migration of perturbed intestinal immunocytes to extraintestinal tissues. Combining Kaede photoconvertible mice and single-cell genomics, we generated a detailed map of migratory trajectories from the colon, at baseline, and in several models of intestinal and extraintestinal inflammation. All lineages emigrated from the colon in an S1P-dependent manner. B lymphocytes represented the largest contingent, with the unexpected circulation of nonexperienced follicular B cells, which carried a gut-imprinted transcriptomic signature. T cell emigration included distinct groups of RORγ and IEL-like CD160 subsets. Gut inflammation curtailed emigration, except for dendritic cells disseminating to lymph nodes. Colon-emigrating cells distributed differentially to distinct sites of extraintestinal models of inflammation (psoriasis-like skin, arthritic synovium, and tumors). Thus, specific cellular trails originating in the gut and influenced by microbiota may shape peripheral immunity in varied ways.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964343PMC
http://dx.doi.org/10.1126/sciimmunol.adi0672DOI Listing

Publication Analysis

Top Keywords

dynamic atlas
4
atlas immunocyte
4
immunocyte migration
4
gut
4
migration gut
4
gut dysbiosis
4
dysbiosis gut
4
gut microbiota
4
microbiota systemic
4
systemic diseases
4

Similar Publications

Background: The World Health Organization launched the Global Programme to Eliminate Lymphatic Filariasis in 2000, which aimed at eradicating the disease by 2030. This goal depends on community mass drug administration and essential care. Despite these efforts, many rural communities still face untreated lymphatic filariasis and lack access to treatment and self-management.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.

Background: Accumulation of amyloid beta in the brain is one of the first events in Alzheimer's disease (AD) and starts decades before symptoms arise. It has been hypothesized that brain areas with higher levels of neuronal activation ('hubs') are more prone to amyloid deposition. In this study, we examined the regional relationship between cortical hubs and longitudinal changes in amyloid pathology in a sample of cognitively healthy older subjects.

View Article and Find Full Text PDF

Background: An intact blood-brain barrier (BBB) is critical for optimal brain health, and even transient or highly localized disruption of the BBB can have devastating consequences for neural functioning. BBB breakdown has been implicated in Alzheimer's Disease (AD) pathogenesis, and elevated BBB permeability has been observed in APOE e4 carriers compared to non-carriers. As prior studies have focused on a priori, AD-vulnerable regions rather than whole-brain analyses, little is understood about broader patterns of BBB breakdown that may relate to AD risk.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Centre for Brain Research (CBR), Indian Institute of Science, Bengaluru, Karnataka, India.

Background: Mild Cognitive Impairment (MCI), a transitional stage between healthy aging and Alzheimer's disease, offers a critical intervention window (Vega and Newhouse, 2014). Diagnosing MCI proves challenging due to subtle neurodegenerative changes. Our study employs graph representations of fMRI time-series, emphasizing connectivity between brain regions (Stam and Reijneveld, 2007).

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.

Background: Non-invasive diffusion-weighted imaging (DWI) can be used to assess cortical microstructure through cortical mean diffusivity (cMD). However, it is still unclear about the dynamic changes of cMD, as well as how it relates to vascular disease and Alzheimer's disease (AD).

Method: We identified 318 cognitively unimpaired (CU) and 305 cognitively impaired (CI) participants with DWI image, β-amyloid (Aβ) positron emission tomography (PET) image from the Alzheimer's Disease Neuroimaging Initiative cohort.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!